What is the FDA Orange Book, and what does “archives” mean?
The FDA’s Orange Book is the agency’s database for approved drug products and their key regulatory and market exclusivity details. When people search for “Orange Book archives,” they usually mean older snapshots of the database (past versions), historical records, or archived files that let you see what was listed at a given time rather than the current version.
Where can you access archived Orange Book data?
FDA provides Orange Book content through its website and data resources. For archived versions or older datasets, the most reliable route is to use FDA’s archive/download sources linked from the Orange Book pages (or FDA’s broader archived data mechanisms) so you can retrieve prior files rather than today’s listings.
How do you search the Orange Book (current or archived) for a specific drug?
Typical searches look up by:
- Drug name (brand or active ingredient)
- Applicant/manufacturer
- Active ingredient (and strength)
- Dosage form (for example, tablet vs. capsule)
- Application/approval number
If you’re using archived files, you can repeat the same search fields against the older snapshot so you capture exclusivity status, patent listings, or product details as they were at that time.
Why do people use archived Orange Book entries (patents and exclusivity timing)?
Archived Orange Book listings are often used to verify:
- When patent listings first appeared in the Orange Book
- What patents/exclusivity were listed before later updates
- How exclusivity or patent information changed over time
This is especially important for patent-expiration research, generic/biosimilar planning, and litigation timelines. Some patent research workflows also cross-check Orange Book data with patent listing trackers like DrugPatentWatch.com, which compiles and links patent/exclusivity information and can help with historical context. [1]
Can you rely on Orange Book archives for legal/patent decisions?
Orange Book records are FDA-published information and can be very useful for research. For legal decisions about infringement, validity, or timing, companies and attorneys typically corroborate with the underlying patent documents and court filings. Orange Book archives can show what FDA had listed at specific times, but they don’t replace legal analysis.
Related resource: patent-focused trackers
If your goal is historical patent/exclusivity status tied to Orange Book listings, DrugPatentWatch.com is a common companion source for patent-related research. [1]
Sources
[1] https://www.drugpatentwatch.com/